重症患者腹腔内念珠菌病诊治专家共识(2025年版)
腹腔内念珠菌病是最常见的侵袭性念珠菌病,在重症患者中发生率高,显著增加医疗费用并影响预后。为规范诊治,北京大学重症医学系(PKUCCM)、中国健康科技促进会重症医学与器官支持专业委员会组织重症、感染、外科、抗真菌皮肤科及临床药师等多学科专家,基于循证医学证据,经标准化流程讨论修订形成本共识。共识共20条核心推荐,涵盖流行病学、高危因素、诊断技术(传统培养、临床风险预测工具、血清学、分子生物学及组织病理学)、诊断标准、分层治疗策略、抗真菌药物选择、感染源控制、联合治疗、降阶梯策略、疗程、预后及特殊类型腹腔内念珠菌病,旨在为重症患者腹腔内念珠菌病的规范化诊治提供专家指导以改善预后。
要点
- 共识由北京大学重症医学系等组织多学科专家制定,共20条核心推荐,覆盖重症患者腹腔内念珠菌病诊治全流程。
- 诊断技术涵盖传统微生物培养、临床风险预测工具、血清学检测、分子生物学检测及组织病理学检查。
- 治疗推荐包括分层治疗策略、抗真菌药物选择、感染源控制、联合治疗、降阶梯策略及疗程。
- 共识同时涉及特殊类型腹腔内念珠菌病及预后评估。
- 目标人群为重症患者,旨在提高规范化诊治水平、改善预后。
适用人群与场景
- 重症患者(危重症人群)中腹腔内念珠菌病的诊断与治疗。
研究设计与关键结果
- 共识由北京大学重症医学系(PKUCCM)、中国健康科技促进会重症医学与器官支持专业委员会组织相关领域专家成立工作组制定。
- 撰写专家基于循证医学证据起草共识,由重症医学科医师、感染科医师、外科医师、抗真菌领域皮肤科医师及临床药师组成的委员会通过标准化流程讨论修订定稿。
- 共识共包含20条核心推荐,聚焦流行病学、高危因素、诊断技术(传统微生物培养、临床风险预测工具、血清学检测、分子生物学检测、组织病理学检查)、诊断标准、分层治疗策略、抗真菌药物选择、感染源控制、联合治疗、降阶梯策略、药物治疗疗程、预后及特殊类型腹腔内念珠菌病。
证据类型、等级与局限
- 证据类型:专家共识,基于循证医学证据制定,经多学科委员会标准化流程讨论修订。
- 局限:原文未报告局限性
对床旁实践的改变
- 共识旨在为重症患者腹腔内念珠菌病的临床诊断与治疗提供专家指导,以期改善患者预后。
指南或共识出处
- Expert consensus on diagnosis and treatment of intra-abdominal candidiasis in critically ill patients (2025 edition),发表于中华危重病急救医学(Zhonghua Wei Zhong Bing Ji Jiu Yi Xue)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Intra-abdominal candidiasis (IAC) is the most common invasive candidiasis, with a high incidence among critically ill patients, which can significantly increase medical costs and affect prognosis. In order to standardize the diagnosis and treatment of IAC in critically ill patients, experts in related fields were organized by the Peking University Critical Care Medicine (PKUCCM), Committee of Critical Care Medicine and Organ Support, China Association for Promotion of Health Science and Technology organized experts in related fields to initiate and form a working group. Expert writers drafted the consensus based on evidence-based medical evidence. A committee composed of critical care physicians, infectious disease physicians, surgeons, dermatologists specializing in antifungal fields, and clinical pharmacists discussed and revised the consensus draft through a standardized process, and finally formulated this consensus. This consensus contains a total of 20 core recommendations, mainly focusing on the epidemiology, high-risk factors, diagnostic techniques and methods (including traditional microbiological culture techniques, clinical risk prediction tools, serological tests, molecular biological tests, and histopathological examinations) of IAC, diagnostic criteria, stratified treatment strategies, antifungal drug selection, control the sources of infection, combined treatment, de-escalation strategies, drug treatment courses, prognosis, and special types of IAC. The aim is to provide expert guidance for the standardized clinical diagnosis and treatment of IAC in critically ill patients, with a view to improving prognosis of patients.
参考来源
- Peking University Critical Care Medicine Committee Of Critical Care Medicine And Organ S, China Association For Promotion Of Health Science And T. [Expert consensus on diagnosis and treatment of intra-abdominal candidiasis in critically ill patients (2025 edition)]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40820526. doi:10.3760/cma.j.cn121430-20250301-00197
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。